UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

RWD45 Inequalities in the Costs and Affordability of a Healthy Diet in Europe between 2017 and 2021

Value in health, 2024-06, Vol.27 (6), p.S365-S365

2024

Volltextzugriff (PDF)

Detection of circovirus in free-ranging brown rats (Rattus norvegicus)

Infection, genetics and evolution, 2024-03, Vol.118, p.105548-105548, Article 105548

2024

Volltextzugriff (PDF)

Low‐burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation

The journal of pathology. Clinical research, 2024-01, Vol.10 (1), p.e351-n/a

2024

Volltextzugriff (PDF)

Next-Generation Sequencing–Based Genomic Profiling of Children with Acute Myeloid Leukemia

The Journal of molecular diagnostics : JMD, 2023-08, Vol.25 (8), p.555-568

2023

Volltextzugriff (PDF)

Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5802

2023

Volltextzugriff (PDF)

Gut Region-Specific Interleukin 1β Induction in Different Myenteric Neuronal Subpopulations of Type 1 Diabetic Rats

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5804

2023

Volltextzugriff (PDF)

Intestinal Region-Dependent Alterations of Toll-Like Receptor 4 Expression in Myenteric Neurons of Type 1 Diabetic Rats

Biomedicines, 2023-01, Vol.11 (1), p.129

2023

Volltextzugriff (PDF)

Hemizygous nonsense variant in the moesin gene (MSN) leads to a new autoimmune phenotype of Immunodeficiency 50

Frontiers in immunology, 2022-09, Vol.13, p.919411-919411

2022

Volltextzugriff (PDF)

P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON‐HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS‐3 TRIAL

HemaSphere, 2022-06, Vol.6 (Suppl), p.1028-1029

2022

Volltextzugriff (PDF)

P1050: THROMBOCYTOPENIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR IN A PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) [MOMENTUM]

HemaSphere, 2022-06, Vol.6 (Suppl), p.940-941

2022

Volltextzugriff (PDF)

S195: MOMENTUM: PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) IN SYMPTOMATIC AND ANEMIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR

HemaSphere, 2022-06, Vol.6, p.96-97

2022

Volltextzugriff (PDF)

P615: BCL2 RESISTANCE MUTATIONS IN A REAL‐WORLD COHORT OF PATIENTS WITH VENETOCLAX‐TREATED CHRONIC LYMPHOCYTIC LEUKAEMIA

HemaSphere, 2022-06, Vol.6, p.514-515

2022

Volltextzugriff (PDF)

P666: ACALABRUTINIB ± OBINUTUZUMAB VS OBINUTUZUMAB + CHLORAMBUCIL IN TREATMENT‐NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA: 5‐YEAR FOLLOW‐UP OF ELEVATE‐TN

HemaSphere, 2022-06, Vol.6, p.564-565

2022

Volltextzugriff (PDF)

S195: MOMENTUM: PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) IN SYMPTOMATIC AND ANEMIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR

HemaSphere, 2022-06, Vol.6, p.96-97

2022

Volltextzugriff (PDF)

S196: ROPEGINTERFERON ALFA‐2B ACHIEVES PATIENT‐SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA: FINAL RESULTS FROM THE PROUD‐PV/CONTINUATION‐PV STUDIES

HemaSphere, 2022-06, Vol.6, p.97-98

2022

Volltextzugriff (PDF)

P308: NOVEL COPY NUMBER ABERRATION‐BASED CLASSIFICATION METHODS REFINE RISK ASSESSMENT IN PEDIATRIC B‐CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

HemaSphere, 2022-06, Vol.6, p.209-210

2022

Volltextzugriff (PDF)

Z‐Selective Fluoroalkenylation of (Hetero)Aromatic Systems by Iodonium Reagents in Palladium‐Catalyzed Directed C−H Activation

Advanced synthesis & catalysis, 2022-01, Vol.364 (2), p.348-354

2022

Volltextzugriff (PDF)

Application of Validation Obligations to Security Concerns

Database and Expert Systems Applications - DEXA 2022 Workshops, p.337-346

Volltextzugriff (PDF)

Some geophysical problems in connection with recent and past crustal movements

I. Internationales Symposium über rezente Erdkrustenbewegungen vom 21. bis 26. Mai 1962 in Leipzig, DDR, 2022, Vol.1962, 2, p.423-432

2022

Volltextzugriff (PDF)

Long-Term Treatment with Pacritinib on a Compassionate Use Basis in Patients with Advanced Myelofibrosis

Blood, 2021-11, Vol.138 (Supplement 1), p.3649-3649

2021

Volltextzugriff (PDF)

Analysing the genomes of two tick-borne encephalitis viruses isolated in Hungary in 1952 and 2019

Ticks and tick-borne diseases, 2021-11, Vol.12 (6), p.101806-101806, Article 101806

2021

Volltextzugriff (PDF)

Screening and monitoring of the BTKC481S mutation in a real‐world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy

British journal of haematology, 2021-07, Vol.194 (2), p.355-364

2021

Volltextzugriff (PDF)

Pharmacogenetics of the Central Nervous System—Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia

Cancers, 2021-05, Vol.13 (10), p.2333

2021

Volltextzugriff (PDF)

The ortho effect in directed C-H activation

Chemical science (Cambridge), 2021-04, Vol.12 (14), p.5152-5163

2021

Volltextzugriff (PDF)

1 – 25 von 178

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(147)
Mit Volltextzugriff
(162)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(109)
Life Sciences & Biomedicine
(77)
Animals
(42)
Humans
(28)
Male
(24)
Female
(22)
Biological And Medical Sciences
(21)
Physical Sciences
(19)
Veterinary Sciences
(19)
Cattle
(18)
Chemistry
(15)
Herpesviridae Infections - Veterinary
(15)
Polymerase Chain Reaction
(14)
Cattle Diseases - Virology
(13)
Medical Sciences
(13)
Herpesviridae Infections - Virology
(12)
Technology
(12)
Hungary
(10)
Legal Medicine
(10)
Medicine, Legal
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

RWD45 Inequalities in the Costs and Affordability of a Healthy Diet in Europe between 2017 and 2021

Detection of circovirus in free-ranging brown rats (Rattus norvegicus)

Low‐burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation

PersonALL: a genetic scoring guide for personalized risk assessment in pediatric B-cell precursor acute lymphoblastic leukemia

Next-Generation Sequencing–Based Genomic Profiling of Children with Acute Myeloid Leukemia

Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax

Gut Region-Specific Interleukin 1β Induction in Different Myenteric Neuronal Subpopulations of Type 1 Diabetic Rats

Intestinal Region-Dependent Alterations of Toll-Like Receptor 4 Expression in Myenteric Neurons of Type 1 Diabetic Rats

Hemizygous nonsense variant in the moesin gene (MSN) leads to a new autoimmune phenotype of Immunodeficiency 50

P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON‐HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS‐3 TRIAL

P1050: THROMBOCYTOPENIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR IN A PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) [MOMENTUM]

S195: MOMENTUM: PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) IN SYMPTOMATIC AND ANEMIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR

P615: BCL2 RESISTANCE MUTATIONS IN A REAL‐WORLD COHORT OF PATIENTS WITH VENETOCLAX‐TREATED CHRONIC LYMPHOCYTIC LEUKAEMIA

P666: ACALABRUTINIB ± OBINUTUZUMAB VS OBINUTUZUMAB + CHLORAMBUCIL IN TREATMENT‐NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA: 5‐YEAR FOLLOW‐UP OF ELEVATE‐TN

S195: MOMENTUM: PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) IN SYMPTOMATIC AND ANEMIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR

S196: ROPEGINTERFERON ALFA‐2B ACHIEVES PATIENT‐SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA: FINAL RESULTS FROM THE PROUD‐PV/CONTINUATION‐PV STUDIES

P308: NOVEL COPY NUMBER ABERRATION‐BASED CLASSIFICATION METHODS REFINE RISK ASSESSMENT IN PEDIATRIC B‐CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

Z‐Selective Fluoroalkenylation of (Hetero)Aromatic Systems by Iodonium Reagents in Palladium‐Catalyzed Directed C−H Activation

Application of Validation Obligations to Security Concerns

Some geophysical problems in connection with recent and past crustal movements

Long-Term Treatment with Pacritinib on a Compassionate Use Basis in Patients with Advanced Myelofibrosis

Analysing the genomes of two tick-borne encephalitis viruses isolated in Hungary in 1952 and 2019

Screening and monitoring of the BTKC481S mutation in a real‐world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy

Pharmacogenetics of the Central Nervous System—Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia

The ortho effect in directed C-H activation

Suchergebnisse filtern